Kimihide Yoshida

1.4k total citations
21 papers, 1.2k citations indexed

About

Kimihide Yoshida is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kimihide Yoshida has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Kimihide Yoshida's work include Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (6 papers). Kimihide Yoshida is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Research Studies (6 papers). Kimihide Yoshida collaborates with scholars based in Japan, United States and Myanmar. Kimihide Yoshida's co-authors include Toyoaki Hida, Tetsuya Mitsudomi, Yasushi Yatabe, Takayuki Kosaka, Masahiro Tsuboi, Hiroyuki Kuwano, Hideki Endoh, Hirohito Tada, Yoshitsugu Horio and Junichi Shimizu and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Kimihide Yoshida

21 papers receiving 1.1k citations

Peers

Countries citing papers authored by Kimihide Yoshida

Since Specialization

Citations

This map shows the geographic impact of Kimihide Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimihide Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimihide Yoshida more than expected).

Fields of papers citing papers by Kimihide Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimihide Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimihide Yoshida. The network helps show where Kimihide Yoshida may publish in the future.

Co-authorship network of co-authors of Kimihide Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Kimihide Yoshida. A scholar is included among the top collaborators of Kimihide Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimihide Yoshida. Kimihide Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EGFR Exon 19 Insertions Show Good Response to Gefitinib, but Short Time to Progression in Japanese Patients 2014 ·Journal of Thoracic Oncology ·Park Jangchul, Chiaki Kondo, Junichi Shimizu, Yoshitsugu Horio, Kimihide Yoshida, Toyoaki Hida	6
2	Crizotinib-induced esophageal ulceration: A novel adverse event of crizotinib 2013 ·Lung Cancer ·Park Jangchul, Kimihide Yoshida, Chiaki Kondo, Junichi Shimizu, Yoshitsugu Horio, Susumu Hijioka, Toyoaki Hida	16
3	Anaplastic lymphoma kinase gene rearrangements in patients with advanced‐stage non‐small‐cell lung cancer: CT characteristics and response to chemotherapy 2013 ·Cancer Medicine ·Park Jangchul, Hidekazu Yamaura, Yasushi Yatabe, Waki Hosoda, Chiaki Kondo, Junichi Shimizu, Yoshitsugu Horio, Kimihide Yoshida, Kosuke Tanaka, Tomoyo Oguri, Yoshihisa Kobayashi, Toyoaki Hida	17
4	Lung Adenocarcinoma Coexistent with Pulmonary Non-tuberculous Mycobacteriosis 2012 ·Haigan ·Naoki Ozeki, Takayuki Fukui, Yukiko Niwa, Kimihide Yoshida, Yasushi Yatabe, Tetsuya Mitsudomi	2
5	Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations 2009 ·Journal of Cancer Research and Clinical Oncology ·Kimihide Yoshida, Yasushi Yatabe, Park Jangchul, (unknown), Ji Young Park, Junichi Shimizu, Yoshitsugu Horio, Keitaro Matsuo, Tetsuya Mitsudomi, Toyoaki Hida	11
6	Synergistic effect of SNDX-275 with lapatinib or erlotinib in breast, lung, or head and neck cancer cell lines expressing HER- 2 2009 ·Journal of Clinical Oncology ·Samir E. Witta, (unknown), Kimihide Yoshida, (unknown), Barbara Frederick, Marileila Varella‐Garcia, P. A. Bunn, F. R. Hirsch	1
7	Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations 2009 ·Clinical Cancer Research ·Satoshi Morita, Isamu Okamoto, Kunihiko Kobayashi, Koichi Yamazaki, Hajime Asahina, Akira Inoue, Koichi Hagiwara, Noriaki Sunaga, Noriko Yanagitani, Toyoaki Hida, Kimihide Yoshida, Tomonori Hirashima, Kosei Yasumoto, Kenji Sugio, Tetsuya Mitsudomi, Masahiro Fukuoka, Toshihiro Nukiwa	156
8	Gefitinib for the treatment of non-small-cell lung cancer 2008 ·Expert Review of Anticancer Therapy ·Toyoaki Hida, (unknown), (unknown), Ji Young Park, Junichi Shimizu, Yoshitsugu Horio, Kimihide Yoshida	49
9	C3-03: Randomized, phase III Study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small-cell lung cancer (NSCLC): WJTOG0105 2007 ·Journal of Thoracic Oncology ·Kimihide Yoshida, Hisao Uejima, Miyako Satouchi, Shinzoh Kudoh, Kazuhiko Nakagawa, Toyoaki Hida, Masaaki Kawahara, (unknown), Kenji Tamura, Masahiro Fukuoka	4
10	Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515 2007 ·Lung Cancer ·Kimihide Yoshida, Takahiko Sugiura, Nobuhide Takifuji, Masaaki Kawahara, Kaoru Matsui, Shinzoh Kudoh, Minoru Takada, Masahiro Fukuoka, Y Ariyoshi, Haruhiko Fukuda, Nagahiro Saijo	48
11	Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer 2007 ·Journal of Thoracic Oncology ·Kimihide Yoshida, Yasushi Yatabe, Ji Young Park, Junichi Shimizu, Yoshitsugu Horio, Keitaro Matsuo, Takayuki Kosaka, Tetsuya Mitsudomi, Toyoaki Hida	143
12	Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer 2007 ·Journal of Thoracic Oncology ·Kimihide Yoshida, Yasushi Yatabe, Ji Young Park, Junichi Shimizu, Yoshitsugu Horio, Keitaro Matsuo, Takayuki Kosaka, Tetsuya Mitsudomi, Toyoaki Hida	98
13	Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib 2006 ·Clinical Cancer Research ·Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Kimihide Yoshida, Toyoaki Hida, Masahiro Tsuboi, Hirohito Tada, Hiroyuki Kuwano, Tetsuya Mitsudomi	480
14	Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer 2004 ·British Journal of Cancer ·Kōichi Goto, Ikuo Sekine, Yutaka Nishiwaki, Ryutaro Kakinuma, Kaoru Kubota, T Matsumoto, Hironobu Ohmatsu, Seiji Niho, Tetsuro Kodama, Tetsu Shinkai, Tomohiro Tamura, Yuichiro Ohe, Hideo Kunitoh, Nobuyuki Yamamoto, Hiroshi Nokihara, Kimihide Yoshida, T Sugiura, Kunihiko Matsui, Nagahiro Saijo	22
15	[Management and types of side effects in chemotherapy for lung cancer]. 2002 ·PubMed ·Kimihide Yoshida	1
16	Association between Smoking Habits and Dopamine Receptor D2 Taql A A2 Allele in Japanese Males: A Confirmatory Study. 2002 ·Journal of Epidemiology ·Nobuyuki Hamajima, Hidemi Ito, Keitaro Matsuo, Toshiko Saito, Kazuo Tajima, Masahiko Ando, Kimihide Yoshida, Takashi Takahashi	33
17	Association between the dopamine D2 receptor A2/A2 genotype and smoking behavior in the Japanese. 2001 ·PubMed ·Kimihide Yoshida, Nobuyuki Hamajima, Ken‐ichi Kozaki, Hiroko Saito, Ken Maeno, Takahiko Sugiura, (unknown), Takashi Takahashi	44
18	Expression of sucrase and intestinal-type alkaline phosphatase in colorectal carcinoms in rats treated with methylazoxymethanol acetate 1998 ·Journal of Cancer Research and Clinical Oncology ·Kimihide Yoshida, Wataru Nakamura, Kazuyuki Hirano, (unknown), Tetsuya Tsukamoto, Masae Tatematsu	9
19	Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type 1994 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Kimihide Yoshida, Hitoshi Iwata, H Nakanishi, Masami Suganuma, Masae Tatematsu	15
20	[Cumulative survival rate of chemotherapy with CDDP for malignant ovarian tumors]. 1990 ·PubMed ·(unknown), Noriaki Usui, Kimihide Yoshida, (unknown), Masashi Suzuki, Hitoshi TAKEUCHI, Hiromi Wada, (unknown), Tatsuo Yamamoto, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact